Israel's Ministry of Health approves the U.S. investigational device exemption trial for BioControl Medical's CardioFit device for treating chronic heart failure.
Israel and Minnesota-based BioControl Medical said it secured clinical trial approval from Israel's Ministry of Health for the Inovate-HF trial of its its CardioFit vagal nerve stimulation system for heart failure.
CardioFit is an implantable device designed to use electrical pulses to stimulate the vagus nerve and help regulate the heart beat.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1e3c3zI
Cap comentari:
Publica un comentari a l'entrada